Tonix Pharmaceuticals (NASDAQ: TNXP) announced it has licensed worldwide rights to TNX-4800, a monoclonal antibody designed for seasonal prevention of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE